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SUMMARY   
 
In this study the effect of diet supplementation with grape pomace (GP) and 
grape pomace extract (GPE) on insulin sensitive tissues (adipose, liver and 
muscle) was evaluated in an experimental model of metabolic syndrome (MetS). 
MetS was developed by giving a high-fat-fructose (HFF) diet to Wistar rats. Six 
weeks of HFF diet induced weight gain, which was partially attenuated by GP (1 g 
Kg-1day-1) and GPE (300 mg Kg-1 day-1) supplementation. HFF diet increased 
systolic blood pressure, triglycerides, insulin resistance (HOMA:IR) and 
inflammation (c-reactive protein (CRP)). Supplementation with GP prevented SBP, 
triglycerides and CRP increased and partially attenuated insulin resistance. On the 
other hand, GPE partially reduced SBP and triglycerides and significantly 
prevented insulin resistance and inflammation. Also, HFF diet induced higher 
triglycerides content and enhanced NADPH oxidase activity in liver. As well, HFF 
diet increased epididymal adipose tissue weight, enlarged adipocytes size, and c-
jun N-terminal kinase (JNK) activation, probably contributing with a pro-
inflammatory cytokine pattern (higher resistin) and lower adiponectin protein 
expression. These alterations may result in an impairment of insulin signaling 
cascade observed in adipose, liver and muscle tissue (IRS1, Akt, and extracellular 
signal-regulated kinases (ERK1/2)) from HFF rats. Supplementation with GP and in 
a greater extent GPE attenuated liver triglyceride content and adiposity and 
restored adipose, liver and muscle response to insulin. These findings show that 
supplementation with GP and GPE in a greater extent can counteract adiposity, 
inflammation, liver damage and impaired insulin signaling associated to MetS, 











































































supporting the utilization of winemaking residues in food industry/human health 




Increased adipocytes size plays an important role in the insulin resistance-
induced metabolic syndrome (MetS) 1, 2, a pathological state characterized by 
hyperglycemia, dyslipidemia (higher levels of triglycerides and lower levels of HDL 
cholesterol), abdominal obesity and hypertension. Hypertrophy of adipocytes, 
particularly from visceral adipose tissue, causes an increase in the production and 
secretion of pro-inflammatory adipocytokines such as tumor necrosis factor alpha 
(TNFα), monocyte chemoattractant protein 1 (MCP-1), resistin, interleukin 6, and 
decrease release of the anti-inflammatory cytokine adiponectin, therefore 
constituting a self feeding circle of inflammation 3.  This inflammatory condition may 
alter the insulin signaling cascade in the liver, skeletal muscle and adipose tissue  
that includes insulin receptor substrate 1 (IRS1) phosphorylation at the serine307 
residue and consequently decrease of AKT and extracellular signal-regulated 
kinases 1/2 (ERK) phosphorylation. Akt activation plays a key role in insulin 
actions, such as enhancement of GLUT4 translocation and glucose transport, 
glycogen and protein synthesis and lipolysis decrease 4, 5. 
Grape pomace (GP) is a waste product, containing predominantly a left-over 
of skins and seeds, generated in the winemaking process which contains relatively 
high amounts of bioactive components like polyphenols and dietary fiber (DF, 











































































especially glycans, cellulose and pectins) 6-8. Polyphenols are bioactive 
compounds found in many fruits and vegetables such as grape, cocoa, and tea 9. 
Several studies have shown that consumption of polyphenols or food-rich in 
polyphenols attenuate the complications associated with MetS 10-13.   
The recovery of bioactive compounds such as phenolics from GP and its 
application has been reviewed 8 and the characterization of Malbec grape pomace 
extract (GPE) was recently reported by Antoniolli et al. 14, showing the potentiality 
of this by-product for a wide range of applications as food ingredients 15, 16. In 
human adipocytes stimulated with TNFα, grape powder extracts attenuate 
inflammation and insulin resistance 17. Regarding GPE, Hogan et al. 18 observed 
that a daily dose of Norton GPE 250 mg Kg-1  of body weight reduced plasma C-
reactive protein (CRP) in mice fed at high fat diet. On the other hand, pomace 
ethanol extract (450 mg kg-1 day) reduced the expression of lipogenic genes in 
liver and plasma triglycerides in rats with high-fat diet 19. 
 In this study it was hypothesized that GP and its extract (GPE), both rich in 
bioactive compounds, may attenuate metabolic alterations associated with a high-
fat-fructose (HFF) diet-induced MetS, focused on adiposity (epididymal adipose 
tissue), liver damage and insulin signaling cascade from liver, skeletal muscle and 















































































Chemical characterization and antioxidant activity of GPE and GP  
The TPC, dietary fiber and antioxidant activity of GPE and GP are shown in 
Table 1. As it is observed, GP presented higher content of DF than GPE, mainly as 
insoluble DF which is because GP is the original crude material. The levels of TPC 
and ORAC were higher in GPE than GP, which is a logical fact taking into account 
that GP represent a crude material not a concentrated extract such as GPE.  
The concentration of low-molecular-weight phenolics found in GPE and GP 
is presented in Table 2. The most abundant compounds quantified in the studied 
samples were the flavan-3-ols (+)-catechin and (–)-epicatechin as well as the 
flavonol quercetin. Amongst non-flavonoids, stilbenes are important because of 
their reported biological properties and nutritional applications. The stilbene trans-
resveratrol was found in GPE and GP samples. The trans-resveratrol contents 
were higher to those reported by Casazza et al. for GPEs of cv. Pinot Noir (11.6 – 
22.4 µg g-1) 20. 
 
Effects of GPE and GP on metabolic variables 
The effect of GPE and GP supplementation on metabolic parameters was 
investigated in HFF rats as shown in Table 3. The evolution of systolic blood 
pressure (SBP) and body weight is shown in Fig. 1A and B, respectively. The daily 
food consumption and water intakes were similar among groups. HFF diet induced 
increase in body weight compared with Ctrl rats, which was partially attenuated in 











































































HFF rats supplemented with GPE and GP. In addition, chronic administration of fat 
and fructose during 6 weeks induced several metabolic alterations such as 
increased SBP, plasma triglycerides, insulin resistance (higher insulin and the 
index of insulin resistance HOMA:IR), and inflammation (higher levels of CRP) in 
comparison with those fed the standard chow. Supplementation with GPE to HFF 
rats partially attenuated SBP and triglycerides, while significantly prevented insulin 
resistance. On the other hand, the addition of GP to HFF rats significantly 
decreased SBP, and triglycerides, but partially reduced the insulin levels and 
HOMA:IR index. Also, GPE and GP supplementation to HFF rats increased the 
levels of HDL and reduced CRP compared with HFF rats. No differences were 
observed in plasma levels of glucose among groups (Table 3). 
 
Supplementation with GPE and GP reduced liver weight, triglycerides content and 
NADPH-oxidase activity. 
Rats receiving HFF diet during 6 weeks increased liver triglycerides content 
compared with those receiving a standard diet. In contrast, HFF supplemented with 
GPE and GP significantly and partially reduced liver triglycerides content, 
respectively and reduced liver weight compared with HFF rats (Fig. 2A and B).  
Next, the activity of NADPH oxidase and the expression of NADPH subunit 
p67phox were evaluated in membrane and cytosolic fraction, respectively.  HFF 
rats significantly increased NADPH oxidase activity in liver with respect to Ctrl rats. 
By other hand, NADPH oxidase activity was markedly attenuated in HFF rats 











































































supplemented with GPE and GP (Fig. 2C). Accordingly, p67 protein expression 
was significantly lower in HFF, suggesting an increased translocation of p67 to 
membrane fraction compared with HFF rats supplemented with GPE and GP (Fig. 
2D). 
Together, the augmented liver triglycerides and enhanced NADPH oxidase 
activity may contribute to an altered insulin signaling. Therefore, we evaluated the 
insulin signaling cascade in liver tissue. Ctrl, HFF and HFF supplemented with 
GPE and GP were injected with saline or insulin solutions (as explained in the 
experimental section), and then basal and insulin-stimulated signaling was 
determined. HFF diet induced phosphorylation of IRS1 (Ser307) in insulin-
stimulated rats that was prevented in HFF upon GPE and GP supplementation. 
Basal and insulin-stimulated Akt (Ser473) phosphorylation was increased in Ctrl 
compared with HFF rats. Only GPE supplementation to HFF rats prevents insulin-
induced Akt decrease. No differences were observed on pERK (Thr202/Tyr204) 
among groups (Fig 3). 
 
Effect of GPE and GP supplementation on adipocyte area in epididymal adipose 
tissue  
Adipocyte hypertrophy is proposed as the leading cause of inflammation and 
insulin resistance. High-fat-fructose diet induced significant increase in epididymal 
adipose tissue weight in comparison to the Ctrl group, which was markedly 
alleviated by administration of both GPE and GP (Fig. 4A). Then, the adipocyte 











































































size in epididymal adipose tissue among groups was evaluated (Fig. 4B). It was 
observed that frequency distribution of adipocyte area was different between Ctrl 
and HFF rats. HFF rats had higher adipocyte area compared to Ctrl group (Fig. 4C 
and D). In contrast, the area of adipocytes from HFF rats supplemented either with 
GPE or GP tended to have a similar distribution of Ctrl group (Fig. 4C and D) 
demonstrating that GPE and GP supplementation reduced both adipocytes weight 
and size.  
 
Supplementation with GPE and GP improves the balance of adipocytokine 
expression and enhanced insulin sensitivity in the epididymal adipose tissue  
Enlarged adipocytes are linked with adipose tissue dysfunction (altered 
adipocytokine balance) and insulin resistance. Then, the protein expression of 
adiponectin and resistin, which are respectively related with anti-inflammatory and 
pro-inflammatory properties, was evaluated. Adiponectin expression was lower and 
resistin was higher in rats fed a HFF diet compared with Ctrl group, which was 
prevented in HFF rats supplemented with GPE and GP (Fig. 5A).  
To investigate whether enlarged and pro-inflammatory adipocytes are 
associated with altered insulin signaling cascade, the molecular basis involved in 
insulin signaling in epididymal adipose tissue was explored. HFF diet induced 
phosphorylation of IRS1 at ser307 in insulin-stimulated rats compared to Ctrl rats, 
which was attenuated in HFF rats supplemented with both GPE and GP. 
Phosphorylation of IRS1 in serine residues is in part regulated by JNK activation. 











































































JNK (Thr183/Tyr185) phosphorylation was increased in insulin-stimulated HFF rats 
compared to Ctrl rats, which was prevented in HFF rats supplemented with GPE. 
Insulin-stimulated Akt (Ser472) and ERK phosphorylation (Thr202/Tyr204) was 
decreased in rats fed a HFF diet compared with Ctrl group and HFF rats 
supplemented with GPE, while GP supplementation to HFF rats elevated pAkt and 
attenuated pERK (Fig 5B). These results indicate that supplementation with GP 
and GPE  in a larger extent attenuated adipose inflammation and improved insulin 
sensitivity. 
 
Effect of GPE and GP supplementation on insulin signaling in skeletal muscle 
tissue from HFF rats.  
Muscle is one of the most important target tissues of insulin. Therefore, we 
evaluated the insulin signaling cascade in muscle tissue. No differences were 
observed on IRS1 (Ser307) phosphorylation in basal and insulin-stimulated rats. 
Basal and insulin-stimulated Akt (Ser473) and ERK (Thr202/Tyr204) 
phosphorylation was decreased in HFF compared with Ctrl rats. GPE 
supplementation to HFF rats significantly prevents insulin-induced Akt and ERK 















































































This study showed that supplementation with GP and GPE in a greater 
extent improved insulin sensitivity due to (at least in part) i) decreased adiposity, 
adipocyte size, and restoring altered adiponectin and resistin protein expression; 
and ii) reduced liver triglyceride content and NADPH-oxidase activity, overall 
improving the metabolic alterations associated with high fat-fructose diet in rats.  
High fat-fructose diet has been described as a model of diet induced-MetS 
in rats 21-23. Interestingly, the addition of fructose to a high fat diet in rats for two 
weeks accelerate the deleterious effects of metabolic alterations 24.   Also, excess 
of fat and/or fructose has been associated with increased liver lipid accumulation 
and oxidative stress which may predispose the development of insulin resistance 
24-26. The liver plays an important role in substrate metabolism and is a primary 
target of insulin action. In the present study it was observed that HFF diet led to 
increased liver triglyceride content and NADPH oxidase activation, measured by 
both enzyme activity and NADPH subunit p67phox expression. NADPH oxidase is 
a major source of cell oxidant production, playing a key role in inflammation and 
insulin resistance 27. The liver response to insulin was also impaired in HFF rats. 
Supplementation with GP and GPE to HFF rats attenuated NADPH oxidase activity 
and partially restored liver insulin signaling.  
On the other hand, increased visceral adipose tissue is one of the most 
important features in the onset of MetS 1. We observed that HFF diet leads to 
increased adipose (epididymal) tissue weight. One of the primary signal causing 
adipose tissue dysfunction in obesity is the hypertrophy of adipocytes, since 
enlarged adipocytes produce a pro-inflammatory adipocytokine pattern contributing 
to adipose insulin resistance 28,29. Resistin has been associated with adiposity, 











































































inflammation and insulin resistance 30, while adiponectin correlates with insulin 
sensitivity and with anti-inflammatory properties that have an important role in the 
prevention of MetS 3. In concordance, in the present work it was found that 
adipocytes from HFF rats were enlarged and presented higher pro-inflammatory 
adipocytokine expression (resistin) and decreased adiponectin. Moreover, the in 
vivo response to insulin by adipose tissue was impaired in the HFF rats as 
evidenced by altered insulin-mediated phosphorylation of IRS1, Akt and ERK1/2. 
Previous reports have shown that animals fed for a long time with high fructose 
and/or fat diet increase adiposity associated with chronic low grade systemic 
inflammation and/or insulin resistance 24, 31, 32. In the present study, 
supplementation with GPE and GP prevented the increase of epididymal fat 
weight, adipocyte size, and altered adipocytokine expression. Also, GPE in a 
greater extent than GP prevent the impairment of adipose tissue response to 
insulin. The anti-inflammatory properties of GPE have been observed in some 
studies. For example, Rodriguez-Morgado et al.33 has shown that grape pomace 
extract (obtained by an enzymatic process)  reduce inflammation in microglia cells 
stimulated with lipopolysaccharide. Hogan et al. 18 found that supplementation with 
Norton GPE in a dose of 250 mgKg-1 d-1 in mice fed with a high fat diet during 12 
weeks attenuate inflammation through reduced plasma CRP levels with no 
differences in plasma parameters of oxidative stress. Also, rats supplemented with 
red GP (5% in the diet) reduces lipopolysaccharide/galactosamine-induced 
inflammation through suppression of NF-κB activation and expression of inducible 
nitric oxide synthase and cyclooxygenase-2 34.  











































































Administration of HFF diet to rats during 6 weeks induced insulin resistance 
as evidenced by HOMA-IR (elevated fasting insulin with normal glucose levels). In 
spite of we did not measure the glucose tolerance test, these results suggest that 
in the HFF rats the increased insulin levels are still capable to 
compensate/maintain comparable glucose concentration. Similar results, with 
normal glucose levels, higher plasma of insulin and HOMA-IR together with altered 
glucose tolerance test has been reported in high fat-high fructose diet in rats 24. 
Supplementation with GPE and GP to HFF rats significantly and partially 
attenuated insulin resistance, respectively. According to these results, 
supplementation with GPE was more effective in attenuating insulin signaling 
cascade in liver, adipose and muscle tissue compared with GP.    
In the present work the chemical identity of the major polyphenols was 
assessed. We found that GP and GPE have important amounts of polyphenols, 
4.2% and 19.5%, respectively. HFF rats supplemented with GP and GPE receive 
approximately 42 mg Kg-1 d-1 and 58 mg Kg-1 d-1 of total polyphenols, respectively. 
Probably these differences are related with the major effectiveness of GPE 
observed. Dietary polyphenols have been proposed to have beneficial effects in 
the prevention of obesity and obesity-related diseases 12, 13. Accordingly, we have 
previously shown that (-)-epicatechin, (+)-catechin and quercetin, the main 
flavonoids found in grapes, ameliorate adipose inflammation and insulin resistance 
in 3T3-L1 adipocytes and in high fructose-fed rats through modulation of pro-
inflammatory and redox signaling 32, 35, 36.  
Also, dietary fiber from GP has been related with important benefits on 
human health 37.  Hence, it was found that GP was more effective to prevent the 











































































increased SBP and triglycerides plasma levels than GPE and these differences are 
probably due to the higher dietary fiber content in GP (53.5%). Interestingly, GPE 
had similar or even greater effect on attenuating insulin resistance, and adipose 
liver, and muscle parameters related with insulin signaling. As far as we know, 
Malbec GP and its extract (GPE) have never been investigated simultaneously on 
alterations related with MetS in rats. Our results provide evidences of the beneficial 
effects of GP and GPE, a by-product of the winemaking process, in the prevention 
of alterations associated to high fat-fructose induced MetS.  
 
CONCLUSION 
The results of the present study show that GPE and GP supplementation 
attenuate altered adipose, liver and muscle insulin signaling in HFF diet induced-
MetS, at least in part through i) modulation of adiposity and adipocytokine 
expression, and ii) reducing liver triglyceride content and NADPH-oxidase activity. 
These findings emphasize the possible nutritive value of GP and GPE with a wide 






Folin-Ciocalteu reagent was purchased from Merck (São Paulo, Brazil). 
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman)-2-carboxylic acid, NaH2PO4.2H2O, 











































































Na2HPO4.12H2O, fluorescein, AAPH (2,2′-azobis-(2-methylpropionamidine) 
dihydrochloride), were supplied from Sigma-Aldrich (St. Louis, MO, USA). 
Standards of gallic acid (99%), (+)-catechin (≥ 99 %), (−)-epicatechin (≥ 95%), 
caffeic acid (99 %), syringic acid (≥ 95 %), coumaric acid (99%), ferulic acid (≥ 
99%), trans-resveratrol (≥ 99%), quercetin hydrate (95%) and cinnamic acid (99%) 
were purchased from Sigma-Aldrich. HPLC-grade MeOH and formic acid were 
purchased from Mallinckrodt Baker (Inc. Pillispsburg, NJ, USA). Ultrapure water 
was obtained from a Milli-Q system (Millipore, Billerica, MA, USA). Fructose was 
purchased from Saporiti Labs (Buenos Aires, Argentina) and Bovine Fat was from 
Recreo Refrigerating Industries S.A.I.C. (Santa Fe, Argentina), HDL, and 
triglyceride concentrations were determined using commercial kits from GTLab 
(Buenos Aires, Argentina).  
Antibodies for p-AKT (#06248) was purchased from Cell Signaling 
Technology (Danvers, MA, USA); AKT (sc-8312), p-ERK (sc-7383) and  ERK (sc-
93)  were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA); IRS1 
(#06-248), p-IRS1 (#07-247) and resistin (AB 3371P) were from Millipore (Billerica, 
MA, USA). The antibody for adiponectin (ADI-905-714-100) was obtained from 
Stressgen (Farmingdale, NY, USA). Nitrocellulose membranes were obtained from 
BIO-RAD (Hercules, CA, USA). The ECL Western blotting system was from GE 
Healthcare (Piscataway, NJ, USA). VAS-2870 was obtained from Enzo Life 
Sciences, Inc. (NY, USA). Unless otherwise noted, reagents were purchased from 
Sigma Chemical Co. (St. Louis, MO). 
Methods 












































































Grape pomace sampling  
This study was performed with GP obtained from Vitis vinifera L. cv. Malbec, 
provided by Catena Institute of Wine from the Adriana vineyard located in 
Gualtallary, Mendoza, Argentina, and harvested in 2013. The vinification procedure 
was conducted with mechanical daily pumping over and contact of the skins and 
seeds with the juice for 11 days. After that, must was pressed, fresh GP samples 
were collected and placed in ice cooled boxes during transportation to the 
laboratory, and then, stored at -20 °C until processing. To obtain lyophilized GP, 
fresh GP were freeze-dried and then kept at –20 °C in dry atmosphere and 
darkness prior use or analysis. The GPE was obtained by solid-liquid extraction 
according to the method of Antoniolli et al. 14. 
To further analysis 500 mg of lyophilized GP, 5 mL of methanol were added 
with vigorously hand shaking, placed in an ultrasonic bath 30 min (stirring every 5 
min), and centrifuged 2 min. From the supernatant TPC, ORAC and phenolic 
analysis were performed. For GP analysis 5 mg of GPE was dissolved in 5 mL of 
ethanol 50% (v/v) aqueous solution. 
 
Total phenolic content  
Absorbance measurements were made with a UV–vis spectrophotometer 
(Cary-50, Varian Inc.). Total phenolic content (TPC) was determined by the Folin–











































































Ciocalteu assay according to Alonso et al. 38. TPC was expressed as milligrams of 
gallic acid equivalents per gram of sample (mg GAE g-1) by using a calibration 
curve with gallic acid as standard (three replicates) in a range between 0 - 200 mg 
L-1 (R2=0,999). 
 
Dietary fiber (AOAC method)  
The total, soluble, and insoluble DF content of Malbec GP and GPE 
samples were determined in quadruplicate according to the AOAC official method 
991.43. (AOAC, 1995) 39.  
 
Antioxidant activity  
The antioxidant activity of GP and GPE was determined by oxygen radical 
absorbance capacity (ORAC). The ORAC was determined as follows: re-
suspended extracts were diluted 1:750 v/v in 75 mmol L-1 potassium phosphate 
buffer (pH 7.0). Fifty microliters aliquots of diluted samples and trolox standards 
were added to a 96-well plate. Then, 100 µL of fluorescein solution were added 
and the mixture was incubated at 37 °C for 7 min before the addition of 50 µL of 
140 mmol L-1 peroxyl radical generator AAPH. Fluorescence was monitored by 
using 485 nm excitation and 538 nm emissions at 1 min intervals for 60 min on a 
fluorometer (Fluoroskan Ascent FL, Thermo Fisher Scientific Inc, Wilmington, DE). 
The area under the curve of the fluorescence decay during 60 min was calculated 











































































and the ORAC was expressed as µmol of trolox equivalents per gram of GPE 
(µmol TE g-1) as described previously 14, 40.  
 
Low-molecular-weight phenolic analysis  
Target polyphenols were determined using a LC-MWD system (Dionex 
Softron GmbH, Thermo Fisher Scientific Inc., Germering, Germany). The 
Chromeleon 7.1 software was used to control all the acquisition parameters of the 
LC-MWD system and also to process the obtained data. The polyphenols 
determination was performed according to Fontana and Bottini 41. LC separations 
were carried out in a reversed-phase Symmetry C18 column (4.6 mm x 250 mm, 5 
µm particle size, Waters, Milford, MA, USA. Ultrapure water with 0.1% FA (A) and 
MeOH (B) were used as mobile phases. Analytes were separated using the 
following gradient: 0 min, 20% B; 0-2 min, 30% B; 2-8 min, 32% B; 8-14 min, 80% 
B; 14-22 min, 20% B; 22-32 min, 20% B. The mobile phase flow was 1 mL min-1 
and the column temperature 35° C. The injection volume for standards and sample 
extracts was 10 µL. The identification and quantification of the target polyphenols 
in GP was achieved by comparing of the retention times (tR) and maximum 
absorbance value of detected peaks in samples of interest with those obtained with 
the injection of pure standards. 
Standard solutions were prepared at 6 concentration levels by diluting 
appropriate volumes of the working standard solution. For the calibration curve, 











































































linear ranges between 0.15 to 50 µg mL-1 were obtained, with coefficient of 
determination (R2) higher than 0.9961 for all the studied polyphenols. 
 
Animal studies 
All animal studies were conducted in accordance with the Guiding Principles 
in the Care and Use of Animals of the US National Institute of Health. All 
procedures were approved by the Comité Institucional para el Cuidado y Uso de 
Animales de Laboratorio (CICUAL, Protocol approval Nº 36/2014). Eight weeks-old 
male Wistar rats (n=24) were used for this 6-weeks supplementation study. Rats 
weighing 250-260 g were housed in cages (3 rats/cage) in a room under conditions 
of controlled temperature (21 - 25 ºC) and humidity with a 12 hour light/dark cycle 
with access to standard rats chow (Gepsa-Feeds, Buenos Aires, Argentina) and 
water ad libitum. Rats were randomly assigned to the following 4 groups (6 rats per 
group): Control diet (Ctrl), high-fat-fructose diet (HFF) (20% fat and 20% fructose 
w/w) added to the standard chow, and HFF supplemented with GPE in a dose of 
300 mg Kg-1 d-1 (HFF+GPE), and GP in a dose of 1g Kg-1 d-1 (HFF+GP) 
approximately. The dose of GPE and GP was incorporated into a pellet mixture, as 
well as fat and fructose. Pellets were re-made and stored at 4 °C, every two-three 
days pellets were weighed and dispensed. Body weight was recorded weekly. 
Water and food daily consumption was estimated by dividing the total consumed in 
each cage by the number of animals housed in it. This estimation was performed 
three times a week and the supply amount was adjusted weekly according to the 
variation in body weight. Systolic blood pressure (SBP) was measured at the 











































































beginning, middle (3 weeks) and at the end (6 weeks) of the protocol by tail-cuff 
method and determined with a plethysmography Koda2® (Kent Scientific 
Corporation, USA). After 6 weeks on the dietary treatments, and after an overnight 
fast, rats were weighed and animals were intraperitoneally injected with insulin (10 
mU g-1 body weight human insulin (Humulin® Eli Lilly and Company)) or saline and 
10 minutes after were anesthetized with ketamine (50 mg Kg-1) and acepromazine 
(1 mg Kg-1) and blood was collected from the abdominal aorta into EDTA tubes. 
Plasma was obtained after centrifugation at 3000 rpm for 15 min at 4 ºC. 
Epididymal adipose tissue, liver and soleus muscle were isolated and flash-frozen 
in liquid nitrogen and then stored at -80 ºC until assayed. Epididymal adipose 
tissue and liver were previously weighted. A piece of epididymal adipose tissue 
collected was immediately fixed in 10% neutral formalin solution for 24 h for 
histological analysis.  
 
Biochemical determinations  
Plasma triglycerides (TG) and HDL cholesterol concentrations were 
determined by enzymatic colorimetric methods using commercial kits (GTLab, 
Buenos Aires, Argentina). Glucose was measure in blood collected from the tail 
using a glucometer (Accu-ChekPerforma, Roche, Buenos Aires, Argentina). 
Hepatic TG was extracted with chloroform/methanol and the extracts were assayed 
for TG content as described previously 42 and assayed for TGs content as 
described above. Insulin was measured using the Ultra Sensitive Insulin ELISA kit 
(Crystal Chem, Downers Grove, IL, USA), and insulin resistance was assessed 











































































using the homeostasis model assessment (HOMA-IR) parameter originally 
described by Mathew et al.43 using the following formula: HOMA-IR (mg dL-1 × 
µU/mL) = fasting glucose (mg dL-1) × fasting insulin (µU/mL)/405.  
Plasma C-reactive protein (CRP) levels were assessed using a Cobas® 
c311 series autoanalyzer (Roche Diagnostics, Mannheim, Germany). 
 
NADPH oxidase activity  
The NAD(P)H oxidase activity in liver membrane fractions was determinate 
using the lucigenin-derived chemiluminescence assay as we previously described 
36. Briefly, liver tissue (1:10 w/v) was homogenized in ice-cold Krebs buffer and 
then centrifuged at 800 g, at 4 ºC for 10 min. The supernatant was collected and 
then centrifuged at 100,000 g for 1 h at 4 ºC. The supernatant (cytosolic fraction) 
was used to determine the NOX subunit p67phox by western blot as described 
below, and the pellet (membrane fraction) was resuspended in Krebs buffer and 
protein concentration measured. Aliquots containing 10 mg of protein were added 
to Krebs buffer containing NADPH (500 µM) and lucigenin (5 µM). Each sample 
was measured in the absence and presence of VAS-2870, a NADPH oxidase 
inhibitor. Light emission was measured for 10 min at 30 s intervals using a Victor 
1420 multilabel counter (Wallac Oy, Turku, Finland), and the area under the curve 
was calculated.  Results are expressed as the difference between AUC in the 
absence and in the presence of VAS-2870, and referred to control values.  
 












































































Liver, muscle and adipose tissue were homogenized in radio-
immunoprecipitation assay (RIPA) buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 
0.1% w/v sodium dodecylsulfate, 1% w/v Triton X-100, 1% sodium deoxycholate, 5 
mM EDTA, 1 mM NaF, 1 mM sodium orthovanadate and protease inhibitors) as 
previously described 32. Homogenates were centrifuged at 13,000 rpm for 30 min, 
the supernatant was collected, and protein concentration measured using the 
Bradford method. Aliquots of homogenates containing 25-40 µg protein were 
denatured with Laemmli buffer, separated by reducing 10–12.5% (w/v) 
polyacrylamide gel electrophoresis, and electroblotted to nitrocellulose 
membranes. Membranes were blotted for 2 h in 5% (w/v) non-fat milk, and 
subsequently incubated in the presence of the corresponding primary antibodies 
(1:1000 dilution for all the antibodies) overnight at 4 °C. After incubation for 90 min 
at room temperature in the presence of the corresponding secondary antibody 
(either HRP or biotinylated antibody followed for 1 hour with streptavidin) the 
conjugates were visualized and quantified by chemiluminescence detection in a 
Luminescent Analyzer Image Reader (LAS-4000) Fujifilm. Densitometry analysis 
was performed using the US National Institute of Health Image 1.66 software 
(Schneider C. A., et al., Division of Computer Research and Technology NIH, 
Bethesda, Maryland, USA). 
 
Histological analysis  











































































Adipocyte hypertrophy degree was evaluated in epididymal adipose tissue 
sections prepared from paraffin-embedded samples and stained with hematoxylin 
and eosin. Images were analyzed using a CCD camera (Nikon, Japan) 20 x 
magnification and adipocyte area was measure using the Image J program. 
 
Statistical analysis 
Data from GPE and GP analysis were mean ± standard deviation. Data from 
animal study were expressed as mean ± standard error media (SEM). The 
statistical significance was assessed by one-way ANOVA followed by Newman-
Keuls Multiple Comparison Test. GraphPad Prism version 5.00 for Windows 
(GraphPad Software, San Diego, CA, USA) was used for all statistical analysis. 
Differences were considered significant at p<0.05.  
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Table 1. Total phenolic content, antioxidant activity, and dietary fiber content 
in Malbec GPE and GP. 
 
 GPE GP 
Total Dietary Fiber (DF) 8.3  ±  0.1 53.5  ±  0.6 
Soluble Dietary Fiber 2.1  ±  0.1 2.7  ±  0.0  
Insoluble Dietary Fiber  6.2  ±  0.1 50.8  ±  0.5  
TPC 195.1  ± 30.0 41.6  ±  2.1  
ORAC 2445.8 ± 324.1 258.1   ±  31.9 
DF: % dry matter; TPC: mg of GAE g-1 GP or GPE; ORAC: µmol TE g-1 GP or 
GPE. Mean value of determinations ± standard deviation. 
 
  











































































Table 2: Levels of target polyphenols in Malbec GPE and GP.  
 




444.8 ± 45.8 
 
62.8 ± 5.7 
Caffeic acid 963.3 ± 38.5 184.2 ± 18.4 
Syringic acid 1471.1 ± 57.2 125.3 ± 13.9 
p-coumaric acid 322.7 ± 14.1 55.2 ± 5.9 
Ferulic acid 115.4 ± 10.7 11.6 ± 1.2 
(+)-catechin 4285.2 ± 136.5 450.8 ± 37.7 
(−)-epicatechin 3298.5 ± 95.8 598.8 ± 54.5 
trans-resveratrol 321.8 ± 16.4 55.9 ± 5.1 
Quercetin 1546 ± 79.1 604.8 ± 74.4 
Average concentrations (µg g-1 lyophilized GP or GPE) with their 















































































Table 3. Effects of grape pomace extract (GPE) and grape pomace (GP) 
supplementation on metabolic parameters in high fat-fructose fed rats (HFF).  
 
 
Parameter  Ctrl  HFF  HFF + GPE HFF + GP 
Food intake (g d
-1
) 23.5 ± 1.1 23.1 ± 0.6  20.6 ± 0.5  20.3 ± 0.8  
Water intake (mL d
-1
) 40.3 ± 2.1 35.3 ± 0.9  33.7 ± 0.9  34.1 ± 1.59  
SBP mmHg  115 ± 5
a
 137 ± 6
b
  121 ± 3
a,b
  119 ± 4
a 
 
Body weight (g)  335 ± 5
a
 382 ± 13
b
  341 ± 10
a,b





)  92.7 ± 4.7 88.2 ± 3.3  88.7 ± 2.5  95.8 ± 1.6  
Insulin (ng mL
-1
) 1.11 ± 0.04
a
 1.75 ± 0.02
b
 1.05 ± 0.23
a
 1.23 ± 0.15
 a,b
 
HOMA:IR  3.6 ± 0.2
a
 5.5 ± 0.2
b
 3.3 ± 0.3
a





)  120 ± 4
a
 154 ± 5
b
  137 ± 4
a,b
  132 ± 8
a
  
HDL cholesterol (mg dL
-1
)  30.4 ± 2.6
a,b
 23.3 ± 1.7
b
  36.3 ± 1.7
a





 55 ± 10
a
 99 ± 8
b
  60 ± 10
a
  54 ± 5
a
  
Metabolic parameters from rats fed for 6 weeks without (Ctrl) or with high fat-fructose diet (HFF 
20% each w/w), in the absence (HFF) or presence of GPE (HFF+GPE 300mg Kg BW-1 d-1), or GP 
(HFF+GP 1g Kg BW-1 d-1). HOMA:IR: homeostatic model assessment of insulin resistance (mg dL-1 
x µU/mL). Values are shown as means ± SEM (n = 6 per group). Values having different 
superscripts are significantly different (P < 0.05, one way ANOVA). SBP: systolic blood pressure, 





















































































Figure 1. Effect of dietary GPE and GP on systolic blood pressure (SBP) and 
body weight gain evolution in HFF rats. SBP was measured at week 0, 3 and 6 
and body weight was measured weekly in eight weeks old rats fed control diets 
without (Ctrl) or with high fat-fructose diet (HFF 20% each w/w), or HFF 
supplemented with GPE 300 mg Kg-1 body weight d-1  and GP 1 g Kg-1 body weight 
d-1. * Significantly different from Ctrl and HFF + GP (n = 6 per group); ** 
significantly different from HFF. 
 
Figure 2.  Effect of dietary GPE and GP supplementation on liver weight, 
triglycerides, NADPH oxidase activity and p67phox subunit expression. 
(A) Liver weight, (B) triglycerides content, (C) membrane NADPH oxidase activity, 
and (D) NOX subunit p67 expression in cytosolic fraction were measured in rats 
fed control diets without (Ctrl) or with high fat-fructose diet (HFF 20% each w/w), or 
HFF supplemented with GPE 300 mg Kg-1 body weight d-1 and GP 1 g Kg-1 body 
weight d-1 (n = 6 per group). Values having different superscripts are significantly 
different, p < 0.05, one-way ANOVA test. 
 
Figure 3. Effect of dietary GPE and GP on liver insulin signaling in HFF rats. 
After 6 weeks on the corresponding diets, rats were fasted overnight and then 
injected with saline or insulin (10 mU/g body weight) and then sacrificed after 10 
min. Phosphorylation of IRS1, Akt, and ERK1/2 is shown for liver tissue. Results 
were expressed as the ratio of phosphorylated/total protein level. Bands were 











































































quantified, and referred to control group values (Ctrl). Results are shown as the 
mean ± SEM of four animals/treatment. 
 
Figure 4. Effect of dietary GPE and GP supplementation on adiposity in HFF 
rats. (A) Epididymal fat weight, (B) representative histological images of 
epididymal adipose tissue stain with Hematoxylin and eosin, (C) mean adipocyte 
diameter and, (D) frequency distribution of adipocyte diameter from rats fed control 
diets without (Ctrl) or with high fat-fructose diet (HFF 20% each w/w), or HFF 
supplemented with GPE 300 mg Kg-1 body weight d-1  and GP 1 g Kg-1 body weight 
d-1 (n = 6 per group).  Values having different superscripts are significantly different, 
p < 0.05, one-way ANOVA test. 
 
Figure 5. GPE and GP supplementation regulates adipocytokine expression 
and enhances insulin signaling in epididymal adipose tissue. (A). Proteins 
involved in metabolic regulation and inflammation (adiponectin, and resistin) were 
determined in epididymal adipose tissue in rats fed control diets without (Ctrl) or 
with high fat-fructose diet (HFF 20% each w/w), or HFF supplemented with GPE 
300 mg Kg-1 body weight d-1  and GP 1 g Kg-1 body weight d-1. Bands were 
quantified and results were expressed as the ratio protein/β-actin protein levels, 
and referred to control group values (Ctrl). (B) Phosphorylation of IRS1, JNK, Akt, 
and ERK1/2 is shown for epididymal adipose tissue. After 6 weeks on the 
corresponding diets, rats were fasted overnight and then injected with saline or 
insulin (10 mU/g body weight) and then sacrificed after 10 min. Results were 
expressed as the ratio of phosphorylated/total protein level, and referred to control 











































































group values (Ctrl). Results are shown as the mean ± SEM of four 
animals/treatment. 
 
Figure 6. Effect of dietary GPE and GP on muscle insulin signaling in HFF 
rats.  Phosphorylation of IRS1, Akt, and ERK1/2 is shown for muscle tissue. After 
6 weeks on the corresponding diets, rats were fasted overnight and then injected 
with saline or insulin (10 mU/g body weight) and then sacrificed after 10 min. 
Bands were quantified and results were expressed as the ratio of 
phosphorylated/total protein level, and referred to control group values (Ctrl). 
Results are shown as the mean ± SEM of four animals/treatment. 
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Figure 1. Effect of dietary GPE and GP on systolic blood pressure (SBP) and body weight gain evolution in 
HFF rats.  
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Figure 2.  Effect of dietary GPE and GP supplementation on liver weight, triglycerides, NADPH oxidase 
activity and p67phox subunit expression.  
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Figure 3. Effect of dietary GPE and GP on liver insulin signaling in HFF rats.  
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Figure 4. Effect of dietary GPE and GP supplementation on adiposity in HFF rats.  
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Figure 5. GPE and GP supplementation regulates adipocytokine expression and enhances insulin signaling in 
epididymal adipose tissue.  
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Figure 5. GPE and GP supplementation regulates adipocytokine expression and enhances insulin signaling in 
epididymal adipose tissue.  
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Figure 6. Effect of dietary GPE and GP on muscle insulin signaling in HFF rats.    
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